Willow's compounded tirzepatide runs $4,788$6,588/year ($399$549 12)
This could be immensely problematic for many people with Type 2 diabetes whove come to depend on the medication
Bank of Americas Alexander Perry held a Buy rating on Planet Fitness with a $75 price target as early as November 7, 2023, citing early signs of benefits to fitness industry from increased usage of GLP-1 drugs. BMOs Simeon Siegel was telling reporters that in a world where GLP-1s become widely accessible, gyms from Planet Fitness all the way up to the highest-end brands are likely going to pull out marketing campaigns looking to boost their membership bases. But the bullish notes were swimming against the tape
The middle-aged man with metabolic syndrome Men in their 40s and 50s with the classic pattern of elevated blood sugar, high triglycerides, low HDL cholesterol, high blood pressure, and central obesity represent a significant portion of tirzepatide users
There are people that have been waiting and waiting and maybe with envy, Doustdar said